S&P Global Inc Q3 2021 Earnings Call Transcript

The following is excerpted from the question-and-answer section of the transcript.

Question: Andrew Owen Nicholas - William Blair & Company L.L.C., Research Division - Analyst : Maybe I'll start with a follow-up to the last question, which is just on the timing of cost synergies. I believe of the $480 million that you'd outlined initially, $390 million were expected in the first 2 years. This additional $100 million or so, is that kind of a first 2-year opportunity? Or is that part of a longer tail? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. OCTOBER 26, 2021 / 12:30PM, SPGI.N - Q3 2021 S&P Global Inc Earnings Call

Question: Andrew Owen Nicholas - William Blair & Company L.L.C., Research Division - Analyst : Understood. And then my next question, appreciate you taking them. It was just on the implied guidance for fourth quarter spend. Obviously, after a really good quarter, it still looks like you're expecting more acceleration in spend. So I'm just wondering, one, what the major drivers of that increased spend are in the fourth quarter and then also as a jumping-off point for 2022.

Question: Andrew Owen Nicholas - William Blair & Company L.L.C., Research Division - Analyst : Yes, it is.

Question: Ashish Sabadra - RBC Capital Markets, Research Division - Analyst : Just on the divestiture and the $420 million of revenues for the divestitures, I believe the ones that are already announced, OPIS, CMM and PetroChem, those were $129 million. I just wanted to confirm if that number is still right. And I was wondering if you could provide any incremental details on the other businesses, any further details on revenues for other businesses?

Question: Ashish Sabadra - RBC Capital Markets, Research Division - Analyst : Okay. That's helpful. And then just a question on the Cap IQ Pro. Obviously, that's gaining pretty good traction with the rollout there. My question was how does that help you post the integration with IHS Markit? Does it make it easier for you to cross-sell IHS data into the Cap IQ customer base with the rollout of the IQ Pro, a pretty solid rollout of the Cap IQ Pro platform?